Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-21,400
Closed -$171K 2608
2023
Q3
$171K Hold
21,400
﹤0.01% 2531
2023
Q2
$257K Hold
21,400
﹤0.01% 2522
2023
Q1
$257K Buy
+21,400
New +$280K ﹤0.01% 2522
2022
Q4
Sell
-1,154
Closed -$10.5K 2745
2022
Q3
$10.5K Buy
+1,154
New +$10.1K ﹤0.01% 2731
2022
Q2
Sell
-22,220
Closed -$138K 2782
2022
Q1
$138K Hold
22,220
﹤0.01% 2713
2021
Q4
$201K Hold
22,220
﹤0.01% 2762
2021
Q3
$230K Hold
22,220
﹤0.01% 2670
2021
Q2
$314K Buy
22,220
+6,490
+41% +$89.7K ﹤0.01% 2641
2021
Q1
$218K Hold
15,730
﹤0.01% 2552
2020
Q4
$192K Hold
15,730
﹤0.01% 2509
2020
Q3
$250K Buy
15,730
+3,410
+28% +$57.6K ﹤0.01% 2346
2020
Q2
$279K Buy
+12,320
New +$206K ﹤0.01% 2302

Other funds holding ZYXI

UBS AM's ZYXI Position: Q4 2023 in Review

UBS AM sold out of Zynex (ZYXI) in Q4 2023, closing a stake of 21,400 shares — an estimated $171K sold.

UBS AM first reported a position in ZYXI in Q2 2020 and held it in 12 quarters. The position peaked at $314K in Q2 2021. 113 funds tracked by Wall St. Rank hold ZYXI as of Q4 2023.

  • UBS AM reported no remaining Zynex position as of Q4 2023 after selling out during the quarter.
  • UBS AM sold 21,400 Zynex shares in Q4 2023, an estimated $171K.
  • UBS AM first reported a position in Zynex in Q2 2020 and held it in 12 quarters.
  • UBS AM's Zynex position peaked at $314K in Q2 2021.
  • 113 funds tracked by Wall St. Rank held Zynex as of Q4 2023.

Based on UBS AM's 13F filing for Q4 2023, filed 14 Feb 2024.